Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The question of whether nicotine, the neuroactive compound of tobacco, is addictive has been open to considerable scientific and public discussion. Although it can serve as a positive reinforcer in several animal species, including man, nicotine is thought to be a weak reinforcer in comparison with addictive drugs such as cocaine and heroin, and has been argued to be habit forming but not addictive. Here we report that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens. These neurochemical and metabolic effects are qualitatively similar to those of other drugs, such as cocaine, amphetamine and morphine, which have strong addictive properties. Our results provide functional and neurochemical evidence that there are specific neurobiological commonalities between nicotine and addictive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine elicits its psychoactive effects by activating neuromediators centrally (e.g. dopamine, serotonin, the catecholamines, etc.).”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Nicotine’s mode of action includes both psychostimulatory and sympathomimetic effects.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Specifically, dopamine-rich brain regions representing the appetitive value of potential rewards such as the ventral striatum (Carlezon & Wise, 1996; Pontieri, Tanda, Orzi, & DiChiara, 1996; Wise, 2004; Galvan, et al., 2005; Haber & Knutson, 2009; Spicer, et al., 2007) show strong signaling during adolescence which may be indicative of earlier maturation (Galvan, et al., 2006; Geier, Terwilliger,”
From Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents (2011) · cites this paper as Pontieri, Tanda, Orzi, & DiChiara, 1996
In the citing paper
“Nicotine administration leads to increased dopamine cell firing in the ventral tegmental area [15] and increased dopamine release in the nucleus accumbens [52], actions which are thought to be critical to the properties of nicotine as an addictive drug.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Handbook of Psychopharmacology
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,746
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Self-citation
Research works printed but not linked: 1
- Orzi, F. et al. Eur. J. Pharmac. (in the press).
Cited by
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
“The nicotinic receptors mainly implicated in the reinforcing actions of nicotine again are localized to the brain mesocorticolimbic dopamine system (Corrigall et al. 1992, 1994; Malin et al. 1993; Pontieri et al. 1996).”
BackgroundFredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
“Conversely, amphetamine, cocaine, and nicotine increase rates of cerebral glucose utilization primarily in the nucleus accumbens (Porrino et al., 1984, 1988; Stein and Fuller, 1992; Porrino, 1993; Pontieri et al., 1996), with a specific metabolic activation only in the shell and not in the core of the nucleus accumben…”
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“Nicotine’s rewarding effects are mediated by the same mesolimbic dopaminergic pathway that is involved in the rewarding effects of many other addictive drugs (Pontieri et al., 1996).”
BackgroundWang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
“Nicotine administered systemically increases extracellular levels of dopamine in the dorsal and ventral (nucleus accumbens) striatu”
BackgroundA Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,261
Damage to the insula disrupts addiction to cigarette smoking
Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007) · Science · doi:10.1126/science.1135926 · Cited by 1,245
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
“It has been postulated that the ability of drugs of abuse to increase DA in limbic brain regions (nucleus accumbens, amygdala) is crucial for their reinforcing effects (Koob and Bloom, 1988; Pontieri et al., 1996).”
BackgroundTanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
Self-citationNucleus accumbens shell and core dopamine: differential role in behavior and addiction
Di Chiara, G. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00286-3 · Cited by 996
Self-citationBlum, K., Braverman, E. R., Holder, J. M., Lubar, J. F., Monastra, V. J., Miller, D., Lubar, J. O., Chen, T. J. H., & Comings, D. E. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10736099 · Cited by 973
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Dopamine and drug addiction: the nucleus accumbens shell connection
Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., & Lecca, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.032 · Cited by 935
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
Topographic organization of the human subcortex unveiled with functional connectivity gradients
Tian, Y., Margulies, D. S., Breakspear, M., & Zalesky, A. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00711-6 · Cited by 784
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
“Nicotine is responsible for the psychoactive actions and addictive properties of tobacc”
BackgroundNeuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782
Kelley, A. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.016 · Cited by 778
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
“A common feature of addictive drugs such as cocaine, amphetamine, morphine and nicotine is that at the doses at which they areself-administrated those drugs increase the concentration of dopamine in the nucleus accumbens (NAcc”
BackgroundLong-term potentiation of excitatory inputs to brain reward areas by nicotine
Mansvelder, H. D., & McGehee, D. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00042-8 · Cited by 720
“and Coen, 1991; Henningfield et al., 1993; Corrigall et (a) Schematic representation of the glutamatergic projections from al., 1994; Pontieri et al., 1996).”
Role of dopamine in the behavioural actions of nicotine related to addiction
Di Chiara, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 681
Self-citationDrug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Relationship between subjective effects of cocaine and dopamine transporter occupancy
Volkow, N. D., Wang, G.-J., Fischman, M. W., Foltin, R. W., Fowler, J. S., Abumrad, N. N., Vitkun, S., Logan, J., Gatley, S. J., Pappas, N., et al. (1997) · Nature · doi:10.1038/386827a0 · Cited by 653
Major Depression and Stages of Smoking: A Longitudinal Investigation
Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.161 · Cited by 633
“Relevant findings come from studies that show nicotine activity on dopaminergic systems in the shell of the nucleus accumbens, systems that are closely tied to the reinforcing functions served by the administration of drugs such as cocaine and nicotine.(35) Separate lines of research link these systems to depressed mo…”
BackgroundLaviola, G., Macrı̀, S., Morley-Fletcher, S., & Adriani, W. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00006-x · Cited by 621
Intense Sweetness Surpasses Cocaine Reward
Lenoir, M., Serre, F., Cantin, L., & Ahmed, S. H. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000698 · Cited by 608
“First, both sweet tastants [18,19] and drugs of abuse [20,21] stimulate dopamine signaling in the ventral striatum, a brain signaling pathway critically involved in reward processing and learning [22,23].”
Drug addiction as dopamine-dependent associative learning disorder
Di Chiara, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00372-6 · Cited by 596
“These studŽ .ies Pontieri et al., 1995, 1996; Tanda et al., 1997a Žshowed that non-psychostimulant drugs including morŽ .”
BackgroundMethodSelf-citationNicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566
Reward system and addiction: what dopamine does and doesn’t do
Di Chiara, G., & Bassareo, V. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.003 · Cited by 531
Parkinson, J. A., Olmstead, M. C., Burns, L. H., Robbins, T. W., & Everitt, B. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02401.1999 · Cited by 555
“…within the NAcc shell (relative to the NAcc core or the dorsal striatum), in response to intravenous infusions of several drugs of abuse (Pontieri et al., 1995, 1996; Carlezon and Wise, 1996; Tanda et al., 1997) and selective increases in energy metabolism as measured by…”
BackgroundRollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533
“An alternative approach to discovering a more efficacious treatment was founded on the knowledge that high affinity a4b2 nAChRs in the mesolimbic dopamine system mediate the reinforcing effects of nicotine ( Pontieri et al., 1996;”
BackgroundFrontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents
Somerville, L. H., Hare, T., & Casey, B. J. (2011) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2010.21572 · Cited by 523
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 498
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Tzschentke, T. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00033-2 · Cited by 481
Cholinergic Interneurons Control Local Circuit Activity and Cocaine Conditioning
Witten, I. B., Lin, S.-C., Brodsky, M., Prakash, R., Diester, I., Anikeeva, P., Gradinaru, V., Ramakrishnan, C., & Deisseroth, K. (2010) · Science · doi:10.1126/science.1193771 · Cited by 467
Are we dependent upon coffee and caffeine? A review on human and animal data
Nehlig, A. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00050-5 · Cited by 453
“…release of dopamine and the rates of cerebral glucose utilization and blood flow in the nucleus accumbens [129, 160–163, 184], with a specific activation of the shell of the nucleus, while there are no changes in these parameters in the core of the nucleus accumbens [150] [160] [162] [163] [184].”
BackgroundThe accumbens: beyond the core-shell dichotomy
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.354 · Cited by 415
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424
“…a dose-dependent increase in extracellular dopamine levels in the shell of the nucleus accumbens, a neurochemical effect shared by other drugs that also serve as positive reinforcers (Nisell, Marcus, Nomikos, & Svensson, 1997; Pontieri et al., 1996; Pontieri, Passarelli, Calo, & Caronti, 1998).”
BackgroundBrain monoamine oxidase A inhibition in cigarette smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14065 · Cited by 423
The neurocircuitry of addiction: an overview
Feltenstein, M. W., & See, R. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.51 · Cited by 421
“, 2006a), nicotine (Pontieri et al., 1996; Lecca et al., 2006b), amphetamines (Di Ciano et al.”
BackgroundHuman neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 416
Cellular mechanisms of nicotine addiction
Dani, J. A., & De Biasi, M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00652-9 · Cited by 408
Rollema, H., Coe, J. W., Chambers, L. K., Hurst, R. S., Stahl, S. M., & Williams, K. E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.003 · Cited by 400
Cohen, C., Perrault, G., Voltz, C., Steinberg, R., & Soubrié, P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00018 · Cited by 396
“, 1999), activates the mesolimbic dopaminergic system (Imperato et al., 1986; Pagliusi et al., 1996; Pontieri et al., 1996), facilitates intracranial self-stimulation (Schaefer and Michael, 1986) and sustains i.”
BackgroundDiergaarde, L., Pattij, T., Poortvliet, I., Hogenboom, F., de Vries, W., Schoffelmeer, A. N. M., & De Vries, T. J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.011 · Cited by 391
Striatal dopamine neurotransmission: Regulation of release and uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.02.001 · Cited by 382
“In vivo, systemic nicotine enhances [DA]o detected by microdialysis [287] and, like cocaine and alcohol, increases the frequency of DA transients in NAc [288].”
BackgroundCigarette Smoking Saturates Brain α4β2 Nicotinic Acetylcholine Receptors
Brody, A. L., Mandelkern, M. A., London, E. D., Olmstead, R. E., Farahi, J., Scheibal, D., Jou, J., Allen, V., Tiongson, E., Chefer, S. I., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.907 · Cited by 367
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“Addictive drugs (including nicotine) increase the basal DA concentration in the NAc shell as measured by microdialysis, but that background increase is smaller or not detected in the dorsolateral striatum (Di Chiara 1999, Pidoplichko et al. 2004, Pontieri et al. 1996, Zhang et al. 2009b).”
BackgroundWooltorton, J. R. A., Pidoplichko, V. I., Broide, R. S., & Dani, J. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03176.2003 · Cited by 363
“Hence, it is mainly the VTA that projects to the areas in which dopaminergic mechanisms have been associated with drugs of addiction, including nicotine (Imperato et al., 1986; Clarke, 1991; Corrigall et al., 1992; Nisell et al., 1994, 1995; Pontieri et al., 1996; Di Chiara, 1999, 2000; Dani and De Biasi, 2001; Dani e…”
BackgroundInfluentialHan, D. H., Lee, Y. S., Na, C., Ahn, J. Y., Chung, U. S., Daniels, M. A., Haws, C. A., & Renshaw, P. F. (2009) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.08.011 · Cited by 343
“Pontieri et al [47] posited that nicotine appears to have an effect on the nucleus accumbens, similar to that of amphetamine derivatives.”
BackgroundA motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
Di Chiara, G. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200108 · Cited by 349
Self-citationOne Is Not Enough: Understanding and Modeling Polysubstance Use
Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, S. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00569 · Cited by 351
Smoking-Induced Ventral Striatum Dopamine Release
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Mandelkern, M. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1211 · Cited by 347
“Furthermore, one study indicated that dopamine concentrations increase more with cocaine (330%) (3) or amphetamine (550%) (3) than with nicotine, while another (4) indicated similarities between nicotine and other addictive drugs.”
BackgroundResultChamptiaux, N., Han, Z.-Y., Bessis, A., Rossi, F. M., Zoli, M., Marubio, L., McIntosh, J. M., & Changeux, J.-P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345
“As many drugs of addiction, nicotine is thought to exert its addictive properties through stimulation of dopamine release in the nucleus accumbens (Nac) (Pontieri et al., 1996; Di Chiara, 2000).”
BackgroundMicrobial Infections, Immunomodulation, and Drugs of Abuse
Friedman, H., Newton, C., & Klein, T. W. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.209-219.2003 · Cited by 338
Bassareo, V., De Luca, M. A., & Di Chiara, G. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04709.2002 · Cited by 339
“On the other hand, conventional and drug rewards have been reported by various studies to differentially affect extracellular DA in different areas (Di Chiara, 1995; Westerink, 1995; Wilson et al., 1995; Pontieri et al., 1995, 1996; Bassareo and Di Chiara, 1997, 1999a; Tanda et al., 1997).”
BackgroundSelf-citationOverexpression of dopamine D2 receptors reduces alcohol self‐administration
Thanos, P. K., Volkow, N. D., Freimuth, P., Umegaki, H., Ikari, H., Roth, G., Ingram, D. K., & Hitzemann, R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00492.x · Cited by 324
Brain nicotinic receptors: structure and regulation, role in learning and reinforcement
Changeux, J.-P., Bertrand, D., Corringer, P.-J., Dehaene, S., Edelstein, S., Léna, C., Le Novère, N., Marubio, L., Picciotto, M., & Zoli, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00040-4 · Cited by 322
The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09282.x · Cited by 321
Neurobiology of Addiction: Toward the Development of New Therapies
KOOB, G. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06682.x · Cited by 317
Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300406 · Cited by 315
“…of DA in the nucleus accumbens [the brain region considered to be crucial to the reinforcing effects of most of the drugs of abuse (Koob and Bloom, 1988; Pontieri et al., 1996)] is considered to be one of the main variables accounting for its highly reinforcing effects (Ritz et al., 1987).”
BackgroundKelly, C., & McCreadie, R. G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1751 · Cited by 317
Shirayama, Y., Ishida, H., Iwata, M., Hazama, G., Kawahara, R., & Duman, R. S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02589.x · Cited by 307
Burkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307
Castro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 290
The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement
Gonzales, R. A., Job, M. O., & Doyon, W. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.002 · Cited by 300
Evidence suggesting the role of specific genetic factors in cigarette smoking.
Lerman, C., Caporaso, N. E., Audrain, J., Main, D., Bowman, E. D., Lockshin, B., Boyd, N. R., & Shields, P. G. (1999) · Health Psychology · doi:10.1037//0278-6133.18.1.14 · Cited by 279
Nicotinic receptor function: new perspectives from knockout mice
Cordero-Erausquin, M., Marubio, L. M., Klink, R., & Changeux, J.-P. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01489-9 · Cited by 295
Luo, S., Kulak, J. M., Cartier, G. E., Jacobsen, R. B., Yoshikami, D., Olivera, B. M., & McIntosh, J. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08571.1998 · Cited by 294
“Changes in CNS norepinephrine levels appear to be involved in mood disorders (for review, see Schatzberg and Nemeroff, 1995; Mongeau et al., 1997), and dopamine appears to play an important role in addictive and psychotic disorders (Kahn and Davis, 1995; Pontieri et al., 1996 ).”
BackgroundTanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 277
Self-citationPatterns of simultaneous polysubstance use in drug using university students
Barrett, S. P., Darredeau, C., & Pihl, R. O. (2006) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.766 · Cited by 271
The concepts of the ventral striatopallidal system and extended amygdala
DE OLMOS, J. S., & HEIMER, L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09258.x · Cited by 281
Levine, A., Huang, Y., Drisaldi, B., Griffin, E. A., Pollak, D. D., Xu, S., Yin, D., Schaffran, C., Kandel, D. B., & Kandel, E. R. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003062 · Cited by 280
Sweet taste potentiates the reinforcing effects of e-cigarettes
Kroemer, N. B., Veldhuizen, M. G., Delvy, R., Patel, B. P., O’Malley, S. S., & Small, D. M. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.07.102 · Cited by 283
Vascular damage from smoking: disease mechanisms at the arterial wall
Powell, J. T. (1998) · Vascular Medicine · doi:10.1177/1358836x9800300105 · Cited by 269
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse
Cossu, G., Ledent, C., Fattore, L., Imperato, A., Böhme, G. A., Parmentier, M., & Fratta, W. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00311-9 · Cited by 272
“A common feature of morphine, cocaine, amphetamine, nicotine and cannabinoids is the stimulation of dopamine release in the limbic system [6,26,36].”
BackgroundImplications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*
Malaiyandi, V., Sellers, E. M., & Tyndale, R. F. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.011 · Cited by 267
A genetic association for cigarette smoking behavior.
Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C. L., Hu, S., Sirota, L. A., Marcus, S. E., Greenberg, B. D., Lucas, F. R., IV, et al. (1999) · Health Psychology · doi:10.1037//0278-6133.18.1.7 · Cited by 270
“different addictive drugs; for example, brain scans of rats ingesting nicotine are essentially indistinguishable from those of rats ingesting cocaine ( Pontieri et al., 1996 ).”
BackgroundWindows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model
Adriani, W., & Laviola, G. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00005 · Cited by 267
“Nicotine has been shown to share most of the characteristics of other addictive drugs (Corrigall et al., 1992, 1994; Pontieri et al., 1996; Merlo-Pich et al., 1997; Stolerman 1999).”
BackgroundEvidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats
Adriani, W., Spijker, S., Deroche-Gamonet, V., Laviola, G., Le Moal, M., Smit, A. B., & Piazza, P. V. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04712.2003 · Cited by 257
“…the addictive properties of nicotine (Stolerman and Shoaib, 1991) are thought to be mediated by activation of the nAChRs (Picciotto et al., 1995) expressed in the ventral tegmental area (VTA), which induces an increase in dopamine (DA) release from mesencephalic DA neurons (Pontieri et al., 1996).”
BackgroundNeuroreceptors and Ion Channels as the Basis for Drug Action: Past, Present, and Future
Narahashi, T. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39034-2 · Cited by 257
“It has been demonstrated that several behavioral effects of ethanol, including reward and reinforcement, seem to require a GABAA and dopamine receptor component (although other neurotransmitter systems are undoubtedly involved as well) (Pontieri et al., 1996; Koob et al., 1998).”
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248
Staley, J. K., Krishnan‐Sarin, S., Zoghbi, S., Tamagnan, G., Fujita, M., Seibyl, J. P., Maciejewski, P. K., O'Malley, S., & Innis, R. B. (2001) · Synapse · doi:10.1002/syn.1084 · Cited by 246
The role of the brain reward system in depression
Naranjo, C. A., Tremblay, L. K., & Busto, U. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00156-7 · Cited by 245
Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02564.x · Cited by 242
“via an excitation of these dopaminergic neurons (Pontieri et al., 1996).”
BackgroundInfluentialDI CHIARA, G., TANDA, G., BASSAREO, V., PONTIERI, F., ACQUAS, E., FENU, S., CADONI, C., & CARBONI, E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09283.x · Cited by 242
Self-citationCastañé, A., Valjent, E., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00118-1 · Cited by 239
“Nicotine administration has been previously reported to produce motivational responses in several behavioural models including the conditioned place preference paradigm (Piccioto et al., 1998; Pontieri et al., 1996; Risinger and Oakes, 1995; Watkins et al., 1999).”
BackgroundDopamine genes and reward dependence in adolescents with excessive Internet video game play
Han, D. H., Lee, Y. S., Yang, K. C., Kim, E. Y., Lyoo, I. K., & Renshaw, P. F. (2007) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31811f465f · Cited by 240
The switching model of latent inhibition: an update of neural substrates
Weiner, I., & Feldon, J. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)02314-0 · Cited by 240
Smoking, quitting, and psychiatric disease: A review
Aubin, H.-J., Rollema, H., Svensson, T. H., & Winterer, G. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.06.007 · Cited by 233
Windle, M., & Windle, R. C. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.69.2.215 · Cited by 229
Rebec, G. V., Christensen, J. R. C., Guerra, C., & Bardo, M. T. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01004-4 · Cited by 235
Solinas, M., Justinova, Z., Goldberg, S. R., & Tanda, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03880.x · Cited by 228
Self-citationStress, Corticotropin‐releasing Factor, and Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07876.x · Cited by 231
The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence
Balfour, D. J. K., Wright, A. E., Benwell, M. E. M., & Birrell, C. E. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00202-3 · Cited by 231
Nicotine Self-Administration Impairs Hippocampal Plasticity
Abrous, D. N., Adriani, W., Montaron, M.-F., Aurousseau, C., Rougon, G., Le Moal, M., & Piazza, P. V. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03656.2002 · Cited by 222
“Nicotine is the neuroactive compound that is considered to be responsible for the development and maintenance of tobacco addiction (Jaffe and Kanzler, 1979; Stolerman and Jarvis, 1995; Pontieri et al., 1996; Merlo Pich et al., 1997).”
Background
Metadata
- Authors
- Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D.
- Affiliations
- Sapienza University of Rome (IT)
- University of Cagliari (IT)
- Istituto Neurologico Mediterraneo (IT)
- Venue
- Nature
- Published
- 1996-07
- Volume
- 382
- Issue
- 6588
- Pages
- 255-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2000363595
- Cited by
- 1,073
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 31 · 2015: 23 · 2014: 34 · 2013: 44 · 2012: 44
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, nicotine dependence, nucleus accumbens, energy metabolism, dopamine signaling, self-administration, cocaine, amphetamine, morphine, drug addiction, positive reinforcement, 2-deoxyglucose autoradiography, cerebral microdialysis
- MeSH terms
- Animals, Deoxyglucose, Dopamine, Energy Metabolism, Injections, Intravenous, Nicotine, Nucleus Accumbens, Microdialysis, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.